← Back to search

Entrada Therapeutics Inc

TRDA · NASDAQ

Research and Development in Biotechnology

ESG Scores

Overall ESG

7.1

Environmental

6.5

Social

4.2

Governance

6.2

Gender Diversity

Female Directors0.25%

CEO GenderMale

Market Data

Price$4.99+0.17 (+3.53%)

Market Cap$194M

P/E Ratio—

EPS$—

52W High$16.45

52W Low$4.11

Beta-0.21